Sandra Redmond brings over 20 years of experience in providing expert economic and modelling advice. Her journey began with a degree and master’s in economics from University College Dublin (UCD), followed by roles as a researcher at UCD and as an economic consultant at Goodbody Stockbrokers in Dublin and Econtech in Australia. In 2005, Sandra joined GlaxoSmithKline (GSK) as a health economics specialist, later becoming Head of Market Access in 2016.

As our Managing Director, Sandra’s expertise in economic consulting and navigating the Irish reimbursement process ensures that she can successfully guide companies through complex market access challenges.

Expertise Highlights:

– Extensive firsthand experience in securing reimbursement for new and existing medicines in Ireland.

– Produced market access strategies, advisory boards, stakeholder mapping, Rapid Reviews, and Health Technology Assessments (HTAs).

– Notable HTAs include those for melanoma, cervical cancer, asthma, and more.

– Published original studies in restless leg syndrome, cervical cancer, and diabetes.

– Award-winning work: “Cost of Type 2 Diabetes,” published in the Irish Medical Journal in 2007.

Explore Sandra’s Research:

Visit our publications page to dive deeper into Sandra’s work.